• AXIM® Biotechnologies Develops Next Generation of its Rapid Neutralizing Antibody Test for COVID-19

    14 days ago - By San Diego Biotechnology

    SAN DIEGO, Oct. 12, 2021 - AXIM Biotechnologies, Inc (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological, COVID-19 and dry eye disease diagnostics, today announced the development of the second generation version of its...
    Read more ...

     

  • Regulus Therapeutics Announces Strategic Prioritization of RGLS8429, its Next-Generation Candidate for the Treatment of Autosomal Dominant Polycystic Kidney Disease

    15 days ago - By San Diego Biotechnology

    SAN DIEGO: SAN DIEGO, Oct. 12, 2021 /PRNewswire/ - Regulus Therapeutics Inc. , a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs , today announced the prioritization of its promising, next-generation candidate, RGLS8429, for the treatment of Autosomal Dominant Polycystic Kidney...
    Read more ...